Stocktoria

Organogenesis Holdings Inc. ORGO

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2016-12-02 · LEI

Organogenesis Holdings Inc. statistics & valuation

Market cap$312.7M
P / E8.4×
P / S0.6×
P / B1.0×
Net margin6.6%
Return on equity12.3%
FCF margin-4.3%
Return on capital9%
Graham number +54.1%$2.79

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($2.79); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-12.20% -4.20% -33.50% -14.80% 5.10% 20.20% 3.40% 1.10% 0.20% 6.60% 2016201720182019202020212022202320242025
Gross margin (%)
65.30% 69.20% 64.40% 70.90% 74.20% 75.60% 76.70% 75.40% 76.00% 2016201720182019202020212022202320242025
Operating margin (%)
-6.30% -2.80% -26.70% -11.40% 7.90% 15.50% 4.90% 2.90% -0.30% 7.90% 2016201720182019202020212022202320242025
Return on equity (%)
-137.80% -69.60% 12.20% 39.00% 5.80% 1.80% 0.30% 12.30% 2016201720182019202020212022202320242025
Shares outstanding
67.0M 91.3M 104.9M 127.7M 133.7M 132.4M 132.7M 131.7M 130.2M 2016201720182019202020212022202320242025
Net debt ($)
$52.1M $49.6M -$14.4M -$39.9M -$31.2M -$37.3M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-5.50% -5.60% -39.60% -17.50% 5.90% 21.30% 3.50% 1.10% 0.20% 6.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-4.50% -3.00% -32.30% -15.10% -3.60% 6.60% -2.00% 1.50% 0.90% -4.30% 2016201720182019202020212022202320242025
Debt / equity (×)
0.89× 0.49× 0.31× 0.27× 0.24× 2016201720182019202020212022202320242025
EPS ($)
-$0.94 -$0.42 $0.15 $0.70 $0.12 $0.04 -$0.01 $0.15 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Organogenesis Holdings Inc. trades at about 12.1× earnings — below its 10-year norm (10-year range 11×–82.5×, median 26.7×).

11× 82.5×

Shaded band = 10-year range (11×–82.5×); dot = today's 12.1×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin—76.0%75.4%76.7%75.6%74.2%70.9%64.4%69.2%65.3%
Operating margin7.9%-0.3%2.9%4.9%15.5%7.9%-11.4%-26.7%-2.8%-6.3%
Net margin6.6%0.2%1.1%3.4%20.2%5.1%-14.8%-33.5%-4.2%-12.2%
FCF margin-4.3%0.9%1.5%-2.0%6.6%-3.6%-15.1%-32.3%-3.0%-4.5%
Return on assets6.2%0.2%1.1%3.5%21.3%5.9%-17.5%-39.6%-5.6%-5.5%
Return on equity12.3%0.3%1.8%5.8%39.0%12.2%-69.6%-137.8%54.8%106.3%
Debt / equity——0.24×0.27×0.31×0.49×0.89×—-3.40×—
Current ratio3.623.692.802.972.742.562.101.270.963.00

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.